Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02695667 · ClinicalTrials.gov registry record
Quantitative Genioglossal Muscle Strength in Obstructive Sleep Apnea (OSAS)
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 13
- Enrollment target
NCT02695667: Clinical Trial study, sponsored by University of New Mexico.
NCT02695667 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02695667 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
Quantitative Genioglossal muscle strength in Obstructive Sleep Apnea (OSAS) defined in the clinical spectrum of subjects with Snoring Disturbance, Oral Appliance Therapy Responsive, and CPAP Responsive
Primary Outcome
quantitative measurement of tongue strength
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-03 |
Why NCT02695667 stopped before completion
NCT02695667 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02695667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02695667 about?
NCT02695667 is a clinical study titled "Quantitative Genioglossal Muscle Strength in Obstructive Sleep Apnea (OSAS)". Quantitative Genioglossal muscle strength in Obstructive Sleep Apnea (OSAS) defined in the clinical spectrum of subjects with Snoring Disturbance, Oral Appliance Therapy Responsive, and CPAP Responsive
What is the current status of trial NCT02695667?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2016-02. Estimated completion is 2017-03.
Who is sponsoring clinical trial NCT02695667?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia